Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 29NIH 13NETWORK 4OTHER_GOV 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 3Rectal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 1

Interventions

Capecitabine 8Fluorouracil 6Radiotherapy 5Leucovorin 5Oxaliplatin 4Laparoscopy 4XELOX 3Cetuximab 3Irinotecan 2Folfox protocol 2Drug Therapy 2Chemoradiotherapy 2selinexor 1citric acid, ispaghula husk, sodium bicarbonate drug combination 1capecitabine-irinotecan combination 1Vitamin D Response Element 1Vi-siblin 1Transanal Endoscopic Microsurgery 1Robotics 1Robotic Surgical Procedures 1Psyllium 1Polyethylene Glycols 1N-hydroxy-4-acetylaminostilbene 1Metronidazole 1Mastectomy, Segmental 1Liver Extracts 1Immunohistochemistry 1Frozen Sections 1Fluorescein Angiography 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Rectal Neoplasms × Folfox protocol × Clear all
NCT03957733 2022-04-06

Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.

King Abdullah Medical City

Phase 2/3 Unknown
338 enrolled
Gastrointestinal

Rectal Neoplasms

NCT00070213 2021-09-27

Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Medical Research Council

Phase 3 Completed
460 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡